Companion Animal Product & Promotions Guide

October 2020

Animal Health Solution - a Henry Schein Animal Health magazine for veterinary professionals

Issue link: https://www.e-digitaleditions.com/i/1289675

Contents of this Issue

Navigation

Page 26 of 31

Enrofloxacin Chewable Tablets • Flavored tablets for the treatment of bacterial infec- tions of the urinary tract, prostate, liver, GI tract, and other body systems • Synthetic chemotherapeutic agent from the class of quinolone carboxylic acid derivatives • Antibacterial activity against a broad spectrum of Gram negative and Gram positive bacteria • Rapidly absorbed from the digestive tract, penetrating into all measured body tissues and fluids • Available in 22.7mg, 68mg, and 136mg tablets © 2020 Covetrus. All Rights Reserved. No copying without permission. Not responsible for typographical errors. Lit. No. 20CVB285 (09/2020) 855.724.3461 | northamerica.covetrus.com CONTRAINDICATIONS: The use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. Consult package outsert for details. WARNINGS: For use in animals only. In rare instances, use of this product in cats has been associated with retinal toxicity. Do not exceed 5 mg/kg of body weight per day in cats. Safety in breeding or pregnant cats has not been established. Keep out of reach of children. Comparable to Baytril ® and Enroquin TM Flavored Tablets Coming Soon!

Articles in this issue

Links on this page

Archives of this issue

view archives of Companion Animal Product & Promotions Guide - October 2020